Tirzepatide, a recently approved medication, is generating considerable buzz within the scientific community. It works differently from existing diabetes medications, targeting two receptors involved in sugar regulation and hunger . Initial research have demonstrated impressive efficacy in reducing blood glucose in individuals with diabetes of the